111 related articles for article (PubMed ID: 2287053)
1. [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
Yamane T; Nakao Y; Yasui Y; Ota K; Ohira H; Inoue T; Furukawa Y; Hiyoshi M; Sasaki A; Kishida T
Jpn J Antibiot; 1990 Nov; 43(11):1843-9. PubMed ID: 2287053
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
[TBL] [Abstract][Full Text] [Related]
4. [Effects of cefoxitin in the treatment of severe infections in patients with hematopoietic disorders].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Tsubakio T; Kawagoe H; Shinohara Y; Nasu T
Jpn J Antibiot; 1982 May; 35(5):1212-22. PubMed ID: 6752459
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effects of micronomicin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y
Jpn J Antibiot; 1985 Aug; 38(8):2129-38. PubMed ID: 3908733
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders].
Sakai H; Sanada M; Shimamoto K; Azuma R; Harada H; Mori H; Niikura H; Omine M
Jpn J Antibiot; 2007 Apr; 60(2):125-31. PubMed ID: 17612259
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
Seriu T; Tsuda S; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H; Yokota S
Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of cefotaxime against severe infections in patients with hematopoietic diseases].
Tsubakio T; Kanayama Y; Yonezawa T; Kitani T; Taniguchi N; Masaoka T; Shibata H; Horiuchi A; Hasegawa H; Kawagoe H
Jpn J Antibiot; 1983 Oct; 36(10):2893-900. PubMed ID: 6325748
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Yamane T; Tanaka K; Hasuike T; Hirai M; Misu K; Ota K; Ohira H; Nakao Y; Yasui Y; Inoue T
Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of panipenem/betamipron as a second line chemotherapy in severe infections associated with hematological disorders].
Nakazawa N; Okamoto T; Kobayashi M; Iwai T; Sasai Y; Tamura A; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tuda S; Ohkawara Y
Jpn J Antibiot; 1998 Aug; 51(8):509-20. PubMed ID: 9836123
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
Mizuno H; Yamao H; Saito H; Ohno R; Hotta T; Ohnishi K; Murate T; Kagami Y; Mitomo Y; Nitta M
Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience of chemotherapy with cefmetazole for severe infections accompanying malignant hematological disorders].
Fujii S; Fujii Y; Inoue Y; Okubo M; Matsutani A; Kaku K; Yaga K; Kaneko T
Jpn J Antibiot; 1989 Mar; 42(3):573-8. PubMed ID: 2664248
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of ceftazidime monotherapy for infections complicated with hematological disorders].
Kuzuyama Y; Tsuda S; Seriu T; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H
Jpn J Antibiot; 1992 May; 45(5):523-9. PubMed ID: 1512938
[TBL] [Abstract][Full Text] [Related]
16. [Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].
Kozuru M; Kurata T; Uike N; Niho Y; Shibuya T; Otsuka T; Yamano Y; Hirota Y; Nishimura J; Katsuno M
Jpn J Antibiot; 1986 Mar; 39(3):701-12. PubMed ID: 3488422
[TBL] [Abstract][Full Text] [Related]
17. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
Kageyama T; Ohyabu H; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Yonezawa T
Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
[TBL] [Abstract][Full Text] [Related]
19. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
Ohno R; Hotta T; Ogura M; Ohnishi K; Morishita T; Murate T; Okumura M; Tanimoto M; Inoue C; Hamaguchi M
Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
